Chemistry:Cysmethynil: Difference between revisions

From HandWiki
(change)
 
(No difference)

Latest revision as of 20:34, 23 October 2022

Cysmethynil
3D model of cysmethynil; blue bonds are resonant, grey are single. Grey atoms are carbon, blue are nitrogen, red is oxygen, & white is hydrogen.
Names
Preferred IUPAC name
2-[5-(3-Methylphenyl)-1-octyl-1H-indol-3-yl]acetamide
Other names
Cysmethynil, 2-(1-octyl-5-m-tolyl-1H-indol-3-yl)acetamide, 9J20
Identifiers
3D model (JSmol)
ChemSpider
UNII
Properties
C25H32N2O
Molar mass 376.544 g·mol−1
Density 1.068 g/cm3
Melting point 247.08 °C (476.74 °F; 520.23 K)
Boiling point 594.156 °C (1,101.481 °F; 867.306 K) at 760 mmHg
0.005429 mg/L
Vapor pressure 1.37×10−12 mmHg at 25 °C
Hazards
Flash point 313.134 °C (595.641 °F; 586.284 K)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Cysmethynil is a chemical compound that is reported to inhibit Icmt, a protein that methylates a Ras protein, which then triggers uncontrolled cell growth. If Icmt no longer activates Ras, cell growth and proliferatation remains under normal control. As such, this small molecule has been investigated as a treatment for cancer. In animal models containing multiple human tumor growths, treatment with cysmethynil causes autophagy in the cell and results in cell death and reduced tumor burden. In prostate cancer cells, cysmethynil inhibits Icmt such that the cell is stuck in the G1 phase, and this leads to the autophagic cell death.

References

2. "Cysmethynil : A New Anti-Cancer Compound That Blocks the Icmt Protein Activation." Cysmethynil : A New Anti-Cancer Compound That Blocks the Icmt Protein Activation. Proceedings of the National Academy of Sciences, 28 Mar. 2005. Web. 19 Oct. 2012. <http://www.rxpgnews.com/cancer-therapy/Cysmethynil_A_New_Anti-Cancer_Compound_that_Blocks_782_782.shtml>.

5. "Arresting Prostate Cancer." The Journal of Biological Chemistry. American Society for Biochemistry and Molecular Biology, n.d. Web. 19 Oct. 2012. <http://www.jbc.org/content/283/27/e99932>.

6. "New Compound Blocks Growth of Cancer Cells." Inside- Duke University Medical Center and Health System. N.p., 04 Apr. 2005. Web. 20 Oct. 2012. <http://inside.duke.edu/article_print.php?id=9726[yes|permanent dead link|dead link}}]>.